Lisa K. Peterson
No Rating Available
(Learn About Our Rating System)

Lisa K. Peterson, PhD

Languages spoken: English

Dr. Peterson is an Associate Professor of Pathology at the University of Utah School of Medicine and a Medical Director in the Immunology division at ARUP Laboratories, where she oversees testing that aids in the diagnosis of autoimmunity and immune deficiency.

Dr. Peterson received her PhD in Experimental Pathology from the University of Utah and completed a postdoctoral fellowship in the Department of Immunology at National Jewish Health and the University of Colorado School of Medicine in Denver, both with an emphasis on autoimmunity and lymphocyte effector function. Dr. Peterson continued her training with a clinical immunology fellowship at the University of Utah. After completing her fellowship, she was board-certified in Medical Laboratory Immunology by the American Board of Medical Laboratory Immunology. Dr. Peterson’s research interests include cellular immunology and autoimmune immunology, with a focus on autoimmune neurology.

Specialties

  • Pathology, Clinical

Board Certification

American Board of Medical Laboratory Immunology

Dr. Peterson is an Associate Professor of Pathology at the University of Utah School of Medicine and a Medical Director in the Immunology division at ARUP Laboratories, where she oversees testing that aids in the diagnosis of autoimmunity and immune deficiency.

Dr. Peterson received her PhD in Experimental Pathology from the University of Utah and completed a postdoctoral fellowship in the Department of Immunology at National Jewish Health and the University of Colorado School of Medicine in Denver, both with an emphasis on autoimmunity and lymphocyte effector function. Dr. Peterson continued her training with a clinical immunology fellowship at the University of Utah. After completing her fellowship, she was board-certified in Medical Laboratory Immunology by the American Board of Medical Laboratory Immunology. Dr. Peterson’s research interests include cellular immunology and autoimmune immunology, with a focus on autoimmune neurology.

Board Certification and Academic Information

Academic Departments Pathology -Associate Professor (Clinical)
Board Certification
American Board of Medical Laboratory Immunology

Education history

Undergraduate Biology; Chemistry Minor - University of Utah B.S.
Doctoral Training Experimental Pathology - University of Utah School of Medicine Ph.D.
Postdoctoral Fellowship Immunology - University of Colorado Denver/National Jewish Health Postdoctoral Fellow
Fellowship Clinical Immunology - University of Utah School of Medicine Fellow

Selected Publications

Journal Article

  1. Liu BM, Martins TB, Peterson LK, Hill H (2021). Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review. Cytokine, 142, 155478.
  2. Kushnir MM, Peterson LK, Strathmann F (2018). Parathyroid hormone related protein concentration in human serum and CSF correlates with age. Clinical biochemistry, 52, 56-60.
  3. Knight V, Askar MZ, Ntrivalas E, Nandiwada SL, Peterson LK, Tebo AE, Kadkhoda K, Schmitz JL, Naides SJ, Snyder MR, Sadighi Akha A (2021). Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI). Journal of immunological methods, 492, 112994.
  4. Lozier BK, Haven TR, Tebo AE, Peterson L (2021). Performance evaluation of a radioimmunoprecipitation assay for the detection of N-type voltage-gated calcium channel antibodies. Journal of immunological methods, 496, 113102.
  5. Peterson LK, Jaskowski TD, La'ulu SL, Tebo A (2018). Antibodies to small ubiquitin-like modifier activating enzyme are associated with a diagnosis of dermatomyositis: results from an unselected cohort. Immunologic research, 66(3), 431-436.
  6. Izadi N, Knight V, Strand M, Hill HR, Peterson LK, Hauk P (2021). An enzyme-linked immunospot assay to evaluate Pneumovax response when on intravenous immunoglobulin. Annals of allergy, asthma & immunology, 128, 61-67.e4.
  7. Jaffe SL, Carlson NG, Peterson LK, Greenlee J (2021). Treatment-responsive primary autoimmune cerebellar ataxia in a patient with IgG and IgM anticerebellar antibodies. European journal of neurology, 28(5), 1771-1773.
  8. Peterson LK, Tebo AE, Wener MH, Copple SS, Fritzler M (2020). Assessment of antinuclear antibodies by indirect immunofluorescence assay: report from a survey by the American Association of Medical Laboratory Immunologists. Clinical chemistry and laboratory medicine, 58(9), 1489-1497.
  9. Ravkov EV, Charlton CM, Barker AP, Hill H, Peterson LK, Slev P, Tebo A, Voelkerding KV, Wittwer CT, Heikal N, Delgado JC, Lázár-Molnár E, Kumánovics (2019). Evaluation of Mass Cytometry in the Clinical Laboratory. Cytometry. Part B, Clinical cytometry, 96(4), 266-274.
  10. Tuttle KD, Krovi SH, Zhang J, Bedel R, Harmacek L, Peterson LK, Dragone LL, Lefferts A, Halluszczak C, Riemondy K, Hesselberth JR, Rao A, O'Connor BP, Marrack P, Scott-Browne J, Gapin (2018). TCR signal strength controls thymic differentiation of iNKT cell subsets. Nature communications, 9(1), 2650.
  11. Williams JP, Abbatemarco JR, Galli JJ, Rodenbeck SJ, Peterson LK, Haven TR, Street M, Rose JW, Greenlee JE, Soldan MMP, Clardy S (2021). Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay. Multiple sclerosis international, 2021, 8692328.
  12. Tebo AE, Schmidt RL, Kadkhoda K, Peterson LK, Chan EKL, Fritzler MJ, Wener M (2021). The antinuclear antibody HEp-2 indirect immunofluorescence assay: a survey of laboratory performance, pattern recognition and interpretation. Auto- immunity highlights, 12(1), 4.
  13. Kulasingam V, Booth RA, Peterson LK, Snyder M (2022). The Journal of Applied Laboratory Medicine Special Issue on Autoimmune Diagnostics. The journal of applied laboratory medicine, 7(1), 1-2.
  14. Tebo AE, Peterson LK, Snyder MR, Lebiedz-Odrobina (2023). Clinical Significance of Anti-U1 Ribonucleoprotein Antibody Is Analyte Dependent: Implications for Laboratory Reporting, Interpretation, and Interassay Correlations. Archives of pathology & laboratory medicine,
  15. Peterson L (2022). Application of vaccine response in the evaluation of patients with suspected B-cell immunodeficiency: Assessment of responses and challenges with interpretation. Journal of immunological methods, 510, 113350.
  16. Smith TL, Haven TR, Zuromski LM, Luong K, Clardy SL, Peterson L (2023). High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting. Frontiers in neurology, 14, 1192644.
  17. Martins TB, Hill HR, Peterson L (2024). Evaluating patient immunocompetence through antibody response to pneumococcal polysaccharide vaccine using a newly developed 23 serotype multiplexed assay. Clinical immunology (Orlando, Fla.), 110295.
  18. Martins TB, Hill HR, Peterson L (2024). Specimen type validation and establishment of normal cytokine reference intervals in cerebrospinal fluid. Journal of immunological methods, 529, 113681.
  19. Luong K, Lozier BK, Novis CL, Smith TL, Zuromski LM, Peterson L (2024). Comparison of three methods for the detection of antibodies against muscle-specific kinase. Journal of immunological methods, 526, 113627.
  20. Hoshina Y, Abbatemarco JR, Rodenbeck SJ, Poon JT, Liu SC, Paz Soldan MM, Greenlee JE, Rose JW, Peterson LK, Johnson L, Delic A, Smith TL, Clardy S (2024). Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Annals of clinical and translational neurology, 11(11), 2846-2854.
  21. Lázár-Molnár E, Peterson L (2025). Clinical utility of the lymphocyte proliferation assay, an in vitro functional readout of the adaptive immune response. Journal of immunological methods, 537, 113819.
  22. Moyle KA, Branch DW, Peterson LK, Guerra MM, Allshouse AA, Benson AE, Salmon J (2025). Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes. Obstetrics and gynecology, 145(1), 55-64.
  23. Hoshina Y, Liu S, Wright MA, Delic A, Wong KH, Kadish R, Galli J, Rose JW, Greenlee JE, Soldán MMP, Klein J, Peterson LK, Smith TL, Clardy S (2025). Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. Journal of neuroimmunology, 407, 578709.
  24. Hoshina Y, Smith TL, Mstat AD, Wong KH, Peterson LK, Zekeridou A, Aboseif A, Coffey C, Wright MA, Banwell B, Dialino-Felix A, Flavin S, Dill L, Titulaer MJ, Day GS, Clardy S (2025). An updated, comprehensive meta-analysis of the treatment of anti-NMDAR encephalitis: Analysis, equipoise, and the urgent need for evidence over anecdote. Journal of neuroimmunology, 405, 578651.
  25. Peterson LK, Nandakumar V, Valentine JF, Delgado JC, Saadalla A (2025). The Utility of the Immunoglobulin A Flag Used in Celiac Disease Serology Testing on a Particle-Based Multianalyte Technology Platform. Clinical chemistry, 71(7), 818-820.

Review

  1. Walker BS, Peterson LK, Koening C, White SK, Schmidt RL, Tebo A (2022). Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis. Autoimmunity reviews, 21(6), 103100.

Letter

  1. Rowe S, Goubran M, Sarmiento Bustamante M, Shyamsundar S, Austin B, McNicholas K, Blommers M, Shi J, Peterson LK, Sepiashvili L, Mattman A, Brandstadter JD, Fajgenbaum DC, Chen LY (2025). Ferritin, C-Reactive Protein, and Soluble CD25 Distinguish TAFRO From HLH. American journal of hematology,